【市場調査レポート】アドレナリン作動性気管支拡張薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Adrenergic Bronchodilator Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。アドレナリン作動性気管支拡張薬のグローバル市場インサイト・予測（～2028年） / Global Adrenergic Bronchodilator Market Insights, Forecast to 2028 / QY2207E09213資料のイメージです。

• レポートコード：QY2207E09213
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、119ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のアドレナリン作動性気管支拡張薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアドレナリン作動性気管支拡張薬の世界市場のxxx％を占める「短時間作用型気管支拡張剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のアドレナリン作動性気管支拡張薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのアドレナリン作動性気管支拡張薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのアドレナリン作動性気管支拡張薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

アドレナリン作動性気管支拡張薬のグローバル主要メーカーには、AstraZeneca、Roche、Mylan、Teva Pharmaceuticals、Sanofi、Sun Pharma、Pfizer、GlaxoSmithKline、Amneal Pharmaceuticals、Akorn、Sunovion、Novartis、Abbott、Gilead Sciences、Neopharm Group、Pieris Pharmaceuticals、Pharmaxis、Century Pharmaceuticals、Boehringer Ingelheim Internationalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

アドレナリン作動性気管支拡張薬市場は、種類と用途によって区分されます。世界のアドレナリン作動性気管支拡張薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
短時間作用型気管支拡張剤、長時間作用型気管支拡張剤

【用途別セグメント】
病院薬局、小売店薬局、オンライン薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- アドレナリン作動性気管支拡張薬製品概要
- 種類別市場（短時間作用型気管支拡張剤、長時間作用型気管支拡張剤）
- 用途別市場（病院薬局、小売店薬局、オンライン薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界のアドレナリン作動性気管支拡張薬販売量予測2017-2028
- 世界のアドレナリン作動性気管支拡張薬売上予測2017-2028
- アドレナリン作動性気管支拡張薬の地域別販売量
- アドレナリン作動性気管支拡張薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別アドレナリン作動性気管支拡張薬販売量
- 主要メーカー別アドレナリン作動性気管支拡張薬売上
- 主要メーカー別アドレナリン作動性気管支拡張薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（短時間作用型気管支拡張剤、長時間作用型気管支拡張剤）
- アドレナリン作動性気管支拡張薬の種類別販売量
- アドレナリン作動性気管支拡張薬の種類別売上
- アドレナリン作動性気管支拡張薬の種類別価格
・用途別市場規模（病院薬局、小売店薬局、オンライン薬局）
- アドレナリン作動性気管支拡張薬の用途別販売量
- アドレナリン作動性気管支拡張薬の用途別売上
- アドレナリン作動性気管支拡張薬の用途別価格
・北米市場
- 北米のアドレナリン作動性気管支拡張薬市場規模（種類別、用途別）
- 主要国別のアドレナリン作動性気管支拡張薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのアドレナリン作動性気管支拡張薬市場規模（種類別、用途別）
- 主要国別のアドレナリン作動性気管支拡張薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のアドレナリン作動性気管支拡張薬市場規模（種類別、用途別）
- 主要国別のアドレナリン作動性気管支拡張薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のアドレナリン作動性気管支拡張薬市場規模（種類別、用途別）
- 主要国別のアドレナリン作動性気管支拡張薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのアドレナリン作動性気管支拡張薬市場規模（種類別、用途別）
- 主要国別のアドレナリン作動性気管支拡張薬市場規模（トルコ、サウジアラビア）
・企業情報
AstraZeneca、Roche、Mylan、Teva Pharmaceuticals、Sanofi、Sun Pharma、Pfizer、GlaxoSmithKline、Amneal Pharmaceuticals、Akorn、Sunovion、Novartis、Abbott、Gilead Sciences、Neopharm Group、Pieris Pharmaceuticals、Pharmaxis、Century Pharmaceuticals、Boehringer Ingelheim International
・産業チェーン及び販売チャネル分析
- アドレナリン作動性気管支拡張薬の産業チェーン分析
- アドレナリン作動性気管支拡張薬の原材料
- アドレナリン作動性気管支拡張薬の生産プロセス
- アドレナリン作動性気管支拡張薬の販売及びマーケティング
- アドレナリン作動性気管支拡張薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- アドレナリン作動性気管支拡張薬の産業動向
- アドレナリン作動性気管支拡張薬のマーケットドライバー
- アドレナリン作動性気管支拡張薬の課題
- アドレナリン作動性気管支拡張薬の阻害要因
・主な調査結果

Adrenergic bronchodilators referred to the drugs that open up the airways. Asthma and chronic bronchitis are treated with them. Overdosing on an adrenergic bronchodilator happens when someone consumes more than the regular or recommended dose of this medication. This could happen by chance or on intent. Adrenergic bronchodilators are also termed as inhaled drugs.
Market Analysis and Insights: Global Adrenergic Bronchodilator Market
The global Adrenergic Bronchodilator market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Short-Acting Bronchodilators accounting for % of the Adrenergic Bronchodilator global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Adrenergic Bronchodilator market size is valued at US$ million in 2021, while the North America and Europe Adrenergic Bronchodilator are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Adrenergic Bronchodilator landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adrenergic Bronchodilator market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adrenergic Bronchodilator market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adrenergic Bronchodilator market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adrenergic Bronchodilator market.
Global Adrenergic Bronchodilator Scope and Market Size
Adrenergic Bronchodilator market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Adrenergic Bronchodilator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Short-Acting Bronchodilators
Long-Acting Bronchodilators
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Company
AstraZeneca
Roche
Mylan
Teva Pharmaceuticals
Sanofi
Sun Pharma
Pfizer
GlaxoSmithKline
Amneal Pharmaceuticals
Akorn
Sunovion
Novartis
Abbott
Gilead Sciences
Neopharm Group
Pieris Pharmaceuticals
Pharmaxis
Century Pharmaceuticals
Boehringer Ingelheim International
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adrenergic Bronchodilator Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Short-Acting Bronchodilators
1.2.3 Long-Acting Bronchodilators
1.3 Market by Application
1.3.1 Global Adrenergic Bronchodilator Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adrenergic Bronchodilator Market Perspective (2017-2028)
2.2 Adrenergic Bronchodilator Growth Trends by Region
2.2.1 Adrenergic Bronchodilator Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adrenergic Bronchodilator Historic Market Size by Region (2017-2022)
2.2.3 Adrenergic Bronchodilator Forecasted Market Size by Region (2023-2028)
2.3 Adrenergic Bronchodilator Market Dynamics
2.3.1 Adrenergic Bronchodilator Industry Trends
2.3.2 Adrenergic Bronchodilator Market Drivers
2.3.3 Adrenergic Bronchodilator Market Challenges
2.3.4 Adrenergic Bronchodilator Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adrenergic Bronchodilator Players by Revenue
3.1.1 Global Top Adrenergic Bronchodilator Players by Revenue (2017-2022)
3.1.2 Global Adrenergic Bronchodilator Revenue Market Share by Players (2017-2022)
3.2 Global Adrenergic Bronchodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adrenergic Bronchodilator Revenue
3.4 Global Adrenergic Bronchodilator Market Concentration Ratio
3.4.1 Global Adrenergic Bronchodilator Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adrenergic Bronchodilator Revenue in 2021
3.5 Adrenergic Bronchodilator Key Players Head office and Area Served
3.6 Key Players Adrenergic Bronchodilator Product Solution and Service
3.7 Date of Enter into Adrenergic Bronchodilator Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adrenergic Bronchodilator Breakdown Data by Type
4.1 Global Adrenergic Bronchodilator Historic Market Size by Type (2017-2022)
4.2 Global Adrenergic Bronchodilator Forecasted Market Size by Type (2023-2028)
5 Adrenergic Bronchodilator Breakdown Data by Application
5.1 Global Adrenergic Bronchodilator Historic Market Size by Application (2017-2022)
5.2 Global Adrenergic Bronchodilator Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Adrenergic Bronchodilator Market Size (2017-2028)
6.2 North America Adrenergic Bronchodilator Market Size by Type
6.2.1 North America Adrenergic Bronchodilator Market Size by Type (2017-2022)
6.2.2 North America Adrenergic Bronchodilator Market Size by Type (2023-2028)
6.2.3 North America Adrenergic Bronchodilator Market Share by Type (2017-2028)
6.3 North America Adrenergic Bronchodilator Market Size by Application
6.3.1 North America Adrenergic Bronchodilator Market Size by Application (2017-2022)
6.3.2 North America Adrenergic Bronchodilator Market Size by Application (2023-2028)
6.3.3 North America Adrenergic Bronchodilator Market Share by Application (2017-2028)
6.4 North America Adrenergic Bronchodilator Market Size by Country
6.4.1 North America Adrenergic Bronchodilator Market Size by Country (2017-2022)
6.4.2 North America Adrenergic Bronchodilator Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Adrenergic Bronchodilator Market Size (2017-2028)
7.2 Europe Adrenergic Bronchodilator Market Size by Type
7.2.1 Europe Adrenergic Bronchodilator Market Size by Type (2017-2022)
7.2.2 Europe Adrenergic Bronchodilator Market Size by Type (2023-2028)
7.2.3 Europe Adrenergic Bronchodilator Market Share by Type (2017-2028)
7.3 Europe Adrenergic Bronchodilator Market Size by Application
7.3.1 Europe Adrenergic Bronchodilator Market Size by Application (2017-2022)
7.3.2 Europe Adrenergic Bronchodilator Market Size by Application (2023-2028)
7.3.3 Europe Adrenergic Bronchodilator Market Share by Application (2017-2028)
7.4 Europe Adrenergic Bronchodilator Market Size by Country
7.4.1 Europe Adrenergic Bronchodilator Market Size by Country (2017-2022)
7.4.2 Europe Adrenergic Bronchodilator Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adrenergic Bronchodilator Market Size (2017-2028)
8.2 Asia-Pacific Adrenergic Bronchodilator Market Size by Type
8.2.1 Asia-Pacific Adrenergic Bronchodilator Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Adrenergic Bronchodilator Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Adrenergic Bronchodilator Market Share by Type (2017-2028)
8.3 Asia-Pacific Adrenergic Bronchodilator Market Size by Application
8.3.1 Asia-Pacific Adrenergic Bronchodilator Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Adrenergic Bronchodilator Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Adrenergic Bronchodilator Market Share by Application (2017-2028)
8.4 Asia-Pacific Adrenergic Bronchodilator Market Size by Region
8.4.1 Asia-Pacific Adrenergic Bronchodilator Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Adrenergic Bronchodilator Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adrenergic Bronchodilator Market Size (2017-2028)
9.2 Latin America Adrenergic Bronchodilator Market Size by Type
9.2.1 Latin America Adrenergic Bronchodilator Market Size by Type (2017-2022)
9.2.2 Latin America Adrenergic Bronchodilator Market Size by Type (2023-2028)
9.2.3 Latin America Adrenergic Bronchodilator Market Share by Type (2017-2028)
9.3 Latin America Adrenergic Bronchodilator Market Size by Application
9.3.1 Latin America Adrenergic Bronchodilator Market Size by Application (2017-2022)
9.3.2 Latin America Adrenergic Bronchodilator Market Size by Application (2023-2028)
9.3.3 Latin America Adrenergic Bronchodilator Market Share by Application (2017-2028)
9.4 Latin America Adrenergic Bronchodilator Market Size by Country
9.4.1 Latin America Adrenergic Bronchodilator Market Size by Country (2017-2022)
9.4.2 Latin America Adrenergic Bronchodilator Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adrenergic Bronchodilator Market Size (2017-2028)
10.2 Middle East & Africa Adrenergic Bronchodilator Market Size by Type
10.2.1 Middle East & Africa Adrenergic Bronchodilator Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Adrenergic Bronchodilator Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Adrenergic Bronchodilator Market Share by Type (2017-2028)
10.3 Middle East & Africa Adrenergic Bronchodilator Market Size by Application
10.3.1 Middle East & Africa Adrenergic Bronchodilator Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Adrenergic Bronchodilator Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Adrenergic Bronchodilator Market Share by Application (2017-2028)
10.4 Middle East & Africa Adrenergic Bronchodilator Market Size by Country
10.4.1 Middle East & Africa Adrenergic Bronchodilator Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Adrenergic Bronchodilator Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Adrenergic Bronchodilator Introduction
11.1.4 AstraZeneca Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Adrenergic Bronchodilator Introduction
11.2.4 Roche Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Adrenergic Bronchodilator Introduction
11.3.4 Mylan Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Adrenergic Bronchodilator Introduction
11.4.4 Teva Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.4.5 Teva Pharmaceuticals Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Adrenergic Bronchodilator Introduction
11.5.4 Sanofi Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Company Details
11.6.2 Sun Pharma Business Overview
11.6.3 Sun Pharma Adrenergic Bronchodilator Introduction
11.6.4 Sun Pharma Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.6.5 Sun Pharma Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Adrenergic Bronchodilator Introduction
11.7.4 Pfizer Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.7.5 Pfizer Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Adrenergic Bronchodilator Introduction
11.8.4 GlaxoSmithKline Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Amneal Pharmaceuticals
11.9.1 Amneal Pharmaceuticals Company Details
11.9.2 Amneal Pharmaceuticals Business Overview
11.9.3 Amneal Pharmaceuticals Adrenergic Bronchodilator Introduction
11.9.4 Amneal Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.9.5 Amneal Pharmaceuticals Recent Developments
11.10 Akorn
11.10.1 Akorn Company Details
11.10.2 Akorn Business Overview
11.10.3 Akorn Adrenergic Bronchodilator Introduction
11.10.4 Akorn Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.10.5 Akorn Recent Developments
11.11 Sunovion
11.11.1 Sunovion Company Details
11.11.2 Sunovion Business Overview
11.11.3 Sunovion Adrenergic Bronchodilator Introduction
11.11.4 Sunovion Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.11.5 Sunovion Recent Developments
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Adrenergic Bronchodilator Introduction
11.12.4 Novartis Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.12.5 Novartis Recent Developments
11.13 Abbott
11.13.1 Abbott Company Details
11.13.2 Abbott Business Overview
11.13.3 Abbott Adrenergic Bronchodilator Introduction
11.13.4 Abbott Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.13.5 Abbott Recent Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Adrenergic Bronchodilator Introduction
11.14.4 Gilead Sciences Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.14.5 Gilead Sciences Recent Developments
11.15 Neopharm Group
11.15.1 Neopharm Group Company Details
11.15.2 Neopharm Group Business Overview
11.15.3 Neopharm Group Adrenergic Bronchodilator Introduction
11.15.4 Neopharm Group Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.15.5 Neopharm Group Recent Developments
11.16 Pieris Pharmaceuticals
11.16.1 Pieris Pharmaceuticals Company Details
11.16.2 Pieris Pharmaceuticals Business Overview
11.16.3 Pieris Pharmaceuticals Adrenergic Bronchodilator Introduction
11.16.4 Pieris Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.16.5 Pieris Pharmaceuticals Recent Developments
11.17 Pharmaxis
11.17.1 Pharmaxis Company Details
11.17.2 Pharmaxis Business Overview
11.17.3 Pharmaxis Adrenergic Bronchodilator Introduction
11.17.4 Pharmaxis Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.17.5 Pharmaxis Recent Developments
11.18 Century Pharmaceuticals
11.18.1 Century Pharmaceuticals Company Details
11.18.2 Century Pharmaceuticals Business Overview
11.18.3 Century Pharmaceuticals Adrenergic Bronchodilator Introduction
11.18.4 Century Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.18.5 Century Pharmaceuticals Recent Developments
11.19 Boehringer Ingelheim International
11.19.1 Boehringer Ingelheim International Company Details
11.19.2 Boehringer Ingelheim International Business Overview
11.19.3 Boehringer Ingelheim International Adrenergic Bronchodilator Introduction
11.19.4 Boehringer Ingelheim International Revenue in Adrenergic Bronchodilator Business (2017-2022)
11.19.5 Boehringer Ingelheim International Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Adrenergic Bronchodilator Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Short-Acting Bronchodilators
Table 3. Key Players of Long-Acting Bronchodilators
Table 4. Global Adrenergic Bronchodilator Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Adrenergic Bronchodilator Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Adrenergic Bronchodilator Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Adrenergic Bronchodilator Market Share by Region (2017-2022)
Table 8. Global Adrenergic Bronchodilator Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Adrenergic Bronchodilator Market Share by Region (2023-2028)
Table 10. Adrenergic Bronchodilator Market Trends
Table 11. Adrenergic Bronchodilator Market Drivers
Table 12. Adrenergic Bronchodilator Market Challenges
Table 13. Adrenergic Bronchodilator Market Restraints
Table 14. Global Adrenergic Bronchodilator Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Adrenergic Bronchodilator Revenue Share by Players (2017-2022)
Table 16. Global Top Adrenergic Bronchodilator by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenergic Bronchodilator as of 2021)
Table 17. Ranking of Global Top Adrenergic Bronchodilator Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Adrenergic Bronchodilator Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adrenergic Bronchodilator Product Solution and Service
Table 21. Date of Enter into Adrenergic Bronchodilator Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adrenergic Bronchodilator Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Adrenergic Bronchodilator Revenue Market Share by Type (2017-2022)
Table 25. Global Adrenergic Bronchodilator Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Adrenergic Bronchodilator Revenue Market Share by Type (2023-2028)
Table 27. Global Adrenergic Bronchodilator Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Adrenergic Bronchodilator Revenue Share by Application (2017-2022)
Table 29. Global Adrenergic Bronchodilator Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Adrenergic Bronchodilator Revenue Share by Application (2023-2028)
Table 31. North America Adrenergic Bronchodilator Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Adrenergic Bronchodilator Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Adrenergic Bronchodilator Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Adrenergic Bronchodilator Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Adrenergic Bronchodilator Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Adrenergic Bronchodilator Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Adrenergic Bronchodilator Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Adrenergic Bronchodilator Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Adrenergic Bronchodilator Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Adrenergic Bronchodilator Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Adrenergic Bronchodilator Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Adrenergic Bronchodilator Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Adrenergic Bronchodilator Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Adrenergic Bronchodilator Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Adrenergic Bronchodilator Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Adrenergic Bronchodilator Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Adrenergic Bronchodilator Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Adrenergic Bronchodilator Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Adrenergic Bronchodilator Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Adrenergic Bronchodilator Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Adrenergic Bronchodilator Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Adrenergic Bronchodilator Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Adrenergic Bronchodilator Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Adrenergic Bronchodilator Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Adrenergic Bronchodilator Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Adrenergic Bronchodilator Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Adrenergic Bronchodilator Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Adrenergic Bronchodilator Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Adrenergic Bronchodilator Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Adrenergic Bronchodilator Market Size by Country (2023-2028) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Adrenergic Bronchodilator Product
Table 64. AstraZeneca Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 65. AstraZeneca Recent Developments
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Adrenergic Bronchodilator Product
Table 69. Roche Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 70. Roche Recent Developments
Table 71. Mylan Company Details
Table 72. Mylan Business Overview
Table 73. Mylan Adrenergic Bronchodilator Product
Table 74. Mylan Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 75. Mylan Recent Developments
Table 76. Teva Pharmaceuticals Company Details
Table 77. Teva Pharmaceuticals Business Overview
Table 78. Teva Pharmaceuticals Adrenergic Bronchodilator Product
Table 79. Teva Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 80. Teva Pharmaceuticals Recent Developments
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Adrenergic Bronchodilator Product
Table 84. Sanofi Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 85. Sanofi Recent Developments
Table 86. Sun Pharma Company Details
Table 87. Sun Pharma Business Overview
Table 88. Sun Pharma Adrenergic Bronchodilator Product
Table 89. Sun Pharma Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 90. Sun Pharma Recent Developments
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Adrenergic Bronchodilator Product
Table 94. Pfizer Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 95. Pfizer Recent Developments
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Adrenergic Bronchodilator Product
Table 99. GlaxoSmithKline Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 100. GlaxoSmithKline Recent Developments
Table 101. Amneal Pharmaceuticals Company Details
Table 102. Amneal Pharmaceuticals Business Overview
Table 103. Amneal Pharmaceuticals Adrenergic Bronchodilator Product
Table 104. Amneal Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 105. Amneal Pharmaceuticals Recent Developments
Table 106. Akorn Company Details
Table 107. Akorn Business Overview
Table 108. Akorn Adrenergic Bronchodilator Product
Table 109. Akorn Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 110. Akorn Recent Developments
Table 111. Sunovion Company Details
Table 112. Sunovion Business Overview
Table 113. Sunovion Adrenergic Bronchodilator Product
Table 114. Sunovion Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 115. Sunovion Recent Developments
Table 116. Novartis Company Details
Table 117. Novartis Business Overview
Table 118. Novartis Adrenergic Bronchodilator Product
Table 119. Novartis Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 120. Novartis Recent Developments
Table 121. Abbott Company Details
Table 122. Abbott Business Overview
Table 123. Abbott Adrenergic Bronchodilator Product
Table 124. Abbott Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 125. Abbott Recent Developments
Table 126. Gilead Sciences Company Details
Table 127. Gilead Sciences Business Overview
Table 128. Gilead Sciences Adrenergic Bronchodilator Product
Table 129. Gilead Sciences Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 130. Gilead Sciences Recent Developments
Table 131. Neopharm Group Company Details
Table 132. Neopharm Group Business Overview
Table 133. Neopharm Group Adrenergic Bronchodilator Product
Table 134. Neopharm Group Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 135. Neopharm Group Recent Developments
Table 136. Pieris Pharmaceuticals Company Details
Table 137. Pieris Pharmaceuticals Business Overview
Table 138. Pieris Pharmaceuticals Adrenergic Bronchodilator Product
Table 139. Pieris Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 140. Pieris Pharmaceuticals Recent Developments
Table 141. Pharmaxis Company Details
Table 142. Pharmaxis Business Overview
Table 143. Pharmaxis Adrenergic Bronchodilator Product
Table 144. Pharmaxis Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 145. Pharmaxis Recent Developments
Table 146. Century Pharmaceuticals Company Details
Table 147. Century Pharmaceuticals Business Overview
Table 148. Century Pharmaceuticals Adrenergic Bronchodilator Product
Table 149. Century Pharmaceuticals Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 150. Century Pharmaceuticals Recent Developments
Table 151. Boehringer Ingelheim International Company Details
Table 152. Boehringer Ingelheim International Business Overview
Table 153. Boehringer Ingelheim International Adrenergic Bronchodilator Product
Table 154. Boehringer Ingelheim International Revenue in Adrenergic Bronchodilator Business (2017-2022) & (US$ Million)
Table 155. Boehringer Ingelheim International Recent Developments
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adrenergic Bronchodilator Market Share by Type: 2021 VS 2028
Figure 2. Short-Acting Bronchodilators Features
Figure 3. Long-Acting Bronchodilators Features
Figure 4. Global Adrenergic Bronchodilator Market Share by Application: 2021 VS 2028
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Adrenergic Bronchodilator Report Years Considered
Figure 9. Global Adrenergic Bronchodilator Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Adrenergic Bronchodilator Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Adrenergic Bronchodilator Market Share by Region: 2021 VS 2028
Figure 12. Global Adrenergic Bronchodilator Market Share by Players in 2021
Figure 13. Global Top Adrenergic Bronchodilator Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenergic Bronchodilator as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Adrenergic Bronchodilator Revenue in 2021
Figure 15. North America Adrenergic Bronchodilator Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Adrenergic Bronchodilator Market Size Market Share by Type (2017-2028)
Figure 17. North America Adrenergic Bronchodilator Market Size Market Share by Application (2017-2028)
Figure 18. North America Adrenergic Bronchodilator Market Size Share by Country (2017-2028)
Figure 19. United States Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Adrenergic Bronchodilator Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Adrenergic Bronchodilator Market Size Market Share by Type (2017-2028)
Figure 23. Europe Adrenergic Bronchodilator Market Size Market Share by Application (2017-2028)
Figure 24. Europe Adrenergic Bronchodilator Market Size Share by Country (2017-2028)
Figure 25. Germany Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Adrenergic Bronchodilator Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Adrenergic Bronchodilator Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Adrenergic Bronchodilator Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Adrenergic Bronchodilator Market Size Share by Region (2017-2028)
Figure 35. China Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Adrenergic Bronchodilator Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Adrenergic Bronchodilator Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Adrenergic Bronchodilator Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Adrenergic Bronchodilator Market Size Share by Country (2017-2028)
Figure 45. Mexico Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Adrenergic Bronchodilator Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Adrenergic Bronchodilator Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Adrenergic Bronchodilator Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Adrenergic Bronchodilator Market Size Share by Country (2017-2028)
Figure 51. Turkey Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Adrenergic Bronchodilator Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. AstraZeneca Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 55. Roche Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 56. Mylan Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 57. Teva Pharmaceuticals Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 59. Sun Pharma Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 60. Pfizer Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 62. Amneal Pharmaceuticals Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 63. Akorn Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 64. Sunovion Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 65. Novartis Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 66. Abbott Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 67. Gilead Sciences Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 68. Neopharm Group Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 69. Pieris Pharmaceuticals Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 70. Pharmaxis Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 71. Century Pharmaceuticals Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 72. Boehringer Ingelheim International Revenue Growth Rate in Adrenergic Bronchodilator Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Global Push-through-package Aluminum Foil for Pharmaceuticals Market Insights, Forecast to 2028
QY2207E10037 2022年7月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界の医薬品プッシュスルー包装用アルミホイルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年...

細胞周期阻害剤のグローバル市場インサイト・予測（～2028年）

Global Cell Cycle Inhibitors Market Insights, Forecast to 2028
QY2207C3471 2022年7月11日 112Pages
新型コロナウイルス感染症のパンデミックにより、世界の細胞周期阻害剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に細胞周期阻害剤の世界市...

カタレプシー治療のグローバル市場インサイト・予測（～2028年）

Global Catalepsy Treatment Market Insights, Forecast to 2028
QY2207C3470 2022年7月11日 125Pages
新型コロナウイルス感染症のパンデミックにより、世界のカタレプシー治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカタレプシー治療の世...

単純疱疹治療のグローバル市場インサイト・予測（～2028年）

Global Cold Sore Treatment Market Insights, Forecast to 2028
QY2207C3477 2022年7月11日 127Pages
新型コロナウイルス感染症のパンデミックにより、世界の単純疱疹治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に単純疱疹治療の世界市場の...

非感染性ブドウ膜炎治療のグローバル市場インサイト・予測（～2028年）

Global Non-infectious Uveitis Treatment Market Insights, Forecast to 2028
QY2207E09261 2022年7月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の非感染性ブドウ膜炎治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に非感染性ブドウ...

配合滅菌製剤薬局のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Compounded Sterile Preparations Pharmacy Market The global Compounded Sterile Preparations Pharmacy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this hea…
カスタム配合療法のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Custom Compounded Therapy Market The global Custom Compounded Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Drug Customization…
世界の薬局用ブリスター包装市場予測（～2028年）：PVC、PVDC、ポリアミド（PA）、ポリエチレン（PE）、アルミニウム、その他 The Pharmacy Blister Packaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
単純疱疹治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Cold Sore Treatment Market The global Cold Sore Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Antiviral Agents accounting fo…
代謝性疾患治療薬のグローバル市場インサイト・予測（～2028年） Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. Market Analysis and Insights: Global Metabolic Disease Drugs Market The global Metabolic Disease Drugs market size is projected to reach US$ million by 2028, f…